How long does the 2023 SCAI consensus recommend DAPT following a DCB procedure?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Practice for Clinical Training 1 (CT1) Day 4 Exam. Enhance your skills with a range of questions designed to test your clinical knowledge. Each question features detailed explanations to help you succeed.

Multiple Choice

How long does the 2023 SCAI consensus recommend DAPT following a DCB procedure?

Explanation:
The 2023 SCAI consensus recommends that dual antiplatelet therapy (DAPT) should be maintained for at least 1 month following a drug-coated balloon (DCB) procedure. This recommendation is based on studies that highlight the importance of DAPT in preventing stent thrombosis and ensuring optimal outcomes after balloon angioplasty with drug-eluting technology. By using DAPT for this duration, healthcare providers aim to reduce the risk of thrombotic events that could arise from the procedure, especially since DCBs release drugs that inhibit smooth muscle proliferation and inflammation, which can lead to better long-term patency of the treated vessel. Other durations of DAPT suggested in the options either exceed the recommended minimum or imply no need for DAPT, which does not align with the consensus recommendations indicating that a period of DAPT is beneficial to support the therapeutic effects of the procedure while minimizing risks.

The 2023 SCAI consensus recommends that dual antiplatelet therapy (DAPT) should be maintained for at least 1 month following a drug-coated balloon (DCB) procedure. This recommendation is based on studies that highlight the importance of DAPT in preventing stent thrombosis and ensuring optimal outcomes after balloon angioplasty with drug-eluting technology.

By using DAPT for this duration, healthcare providers aim to reduce the risk of thrombotic events that could arise from the procedure, especially since DCBs release drugs that inhibit smooth muscle proliferation and inflammation, which can lead to better long-term patency of the treated vessel.

Other durations of DAPT suggested in the options either exceed the recommended minimum or imply no need for DAPT, which does not align with the consensus recommendations indicating that a period of DAPT is beneficial to support the therapeutic effects of the procedure while minimizing risks.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy